Publications by authors named "Mathilde S Larsen"

Claim this Profile
F
Fine needle and core needle ultrasound guided biopsies for assessing suspected melanoma metastasis in lymph nodes and subcutaneous tissue.
David N Salim, Magnus P B Obinah, Niels K Ternov, Mark J D McCullagh, Mathilde S Larsen

J Surg Oncol· November 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Real-World Impact of Immune Checkpoint Inhibitors in Metastatic Uveal Melanoma.
Kalijn Fredrike Bol, Eva Ellebaek, Lise Hoejberg, Mette Marie Bagger, Mathilde Skaarup Larsen

Cancers (Basel)· October 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Lymphomatoid papulosis type D or an aggressive epidermotropic CD8(+) cytotoxic T-cell lymphoma?
Rosa Marie Andersen, Mathilde Skaarup Larsen, Tim Svenstrup Poulsen, Anne Falensteen Lauritzen, Lone Skov

Acta Derm Venereol· July 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Estrogen receptor α is the major driving factor for growth in tamoxifen-resistant breast cancer and supported by HER/ERK signaling.
Susan Thrane, Anne E Lykkesfeldt, Mathilde S Larsen, Boe S Sorensen, Christina W Yde

Breast Cancer Res Treat· May 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Association of tissue inhibitor of metalloproteinases-1 and Ki67 in estrogen receptor positive breast cancer.
Christina Bjerre, Ann Knoop, Karsten Bjerre, Mathilde S Larsen, Katrine L Henriksen

Acta Oncol· January 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Carboplatin treatment of antiestrogen-resistant breast cancer cells.
Mathilde S Larsen, Christina W Yde, Ib J Christensen, Anne E Lykkesfeldt

Int J Oncol· November 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Activated HER-receptors in predicting outcome of ER-positive breast cancer patients treated with adjuvant endocrine therapy.
Mathilde S Larsen, Karsten Bjerre, Anne E Lykkesfeldt, Anita Giobbie-Hurder, Anne-Vibeke Laenkholm

Breast· October 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Prognostic value of Bcl-2 in two independent populations of estrogen receptor positive breast cancer patients treated with adjuvant endocrine therapy.
Mathilde S Larsen, Karsten Bjerre, Anita Giobbie-Hurder, Anne-Vibeke Lænkholm, Katrine L Henriksen

Acta Oncol· July 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
Q
Quantifying mast cells in bladder pain syndrome by immunohistochemical analysis.
Mathilde S Larsen, Svend Mortensen, Jørgen Nordling, Thomas Horn

BJU Int· July 2008

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
[
[Immunosuppressive treatment of the myelodysplastic syndrome].
Mathilde Skaarup Larsen, Hans Carl Hasselbalch

Ugeskr Laeger· June 2003

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
[
[Asystole following synchronized DC conversion].
Mathilde Skaarup Larsen, Poul Ebbe Nielsen

Ugeskr Laeger· April 2002

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis